NRSG265 Exam Complete Questions and Correct Detailed
Answers (Verified Answers)
Type 1 DM Patho
Ans: - immune response against beta cells
- beta cell destruction
- decreased insulin released
- GLUT 4 not activated
- Glucose remains in blood
Type 2 DM Patho
Ans: - increased insulin sensitivity
- reduced insulin binding site
- reduced insulin binding
- decreased beta cell responsiveness
Metformin MoA
Ans: - reduces hepatic release of glucose
- decreased intestonal absorption
- increased insulin sensitivity
Glicazide MoA
pg. 1
, March 25
Ans: Stimulates insulin secretion from beta cells
DKA Clinical Manifestations
Ans: - BGL >11
- presence of ketones
- high serum levels
DKA signs and symptoms
Ans: fruity breath, polyuria, polydipsia, tachycardia
HHS
Ans: severe hyperglycemia, serum hyperosmolarity, and dehydration
HHS Patho
Ans: - osmotic diuresis
- fluid loss -> dehydration
- electrolyte imbalance
diabetic nephropathy
pg. 2